Anti-GARS/ CMT2D/ DSMAV functional antibody

Anti-GARS/ CMT2D/ DSMAV functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to GARS/GARS products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1450-Ab-1/ GM-Tg-hg-SE1450-Ab-2Anti-Human GARS monoclonal antibodyHuman
GM-Tg-rg-SE1450-Ab-1/ GM-Tg-rg-SE1450-Ab-2Anti-Rat GARS monoclonal antibodyRat
GM-Tg-mg-SE1450-Ab-1/ GM-Tg-mg-SE1450-Ab-2Anti-Mouse GARS monoclonal antibodyMouse
GM-Tg-cynog-SE1450-Ab-1/ GM-Tg-cynog-SE1450-Ab-2Anti-Cynomolgus/ Rhesus macaque GARS monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1450-Ab-1/ GM-Tg-felg-SE1450-Ab-2Anti-Feline GARS monoclonal antibodyFeline
GM-Tg-cang-SE1450-Ab-1/ GM-Tg-cang-SE1450-Ab-2Anti-Canine GARS monoclonal antibodyCanine
GM-Tg-bovg-SE1450-Ab-1/ GM-Tg-bovg-SE1450-Ab-2Anti-Bovine GARS monoclonal antibodyBovine
GM-Tg-equg-SE1450-Ab-1/ GM-Tg-equg-SE1450-Ab-2Anti-Equine GARS monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1450-Ab-1/ GM-Tg-hg-SE1450-Ab-2; GM-Tg-rg-SE1450-Ab-1/ GM-Tg-rg-SE1450-Ab-2;
GM-Tg-mg-SE1450-Ab-1/ GM-Tg-mg-SE1450-Ab-2; GM-Tg-cynog-SE1450-Ab-1/ GM-Tg-cynog-SE1450-Ab-2;
GM-Tg-felg-SE1450-Ab-1/ GM-Tg-felg-SE1450-Ab-2; GM-Tg-cang-SE1450-Ab-1/ GM-Tg-cang-SE1450-Ab-2;
GM-Tg-bovg-SE1450-Ab-1/ GM-Tg-bovg-SE1450-Ab-2; GM-Tg-equg-SE1450-Ab-1/ GM-Tg-equg-SE1450-Ab-2
Products NameAnti-GARS monoclonal antibody
Formatmab
Target NameGARS
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-GARS benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1450-Ag-1Recombinant multi-species GARS/ CMT2D/ DSMAV protein


    Target information

    Target IDGM-SE1450
    Target NameGARS
    Gene ID2617,353172,297113,697526,100856659,101094998,408010,100054985
    Gene Symbol and SynonymsCMT2D,DSMAV,GARS,GARS1,Gena201,GENA202,GlyRS,HMN5,HMN5A,Nmf249,RGD1559871,Sgrp23,SMAD1,SMAJI
    Uniprot AccessionP41250,Q5I0G4
    Uniprot Entry NameGARS_HUMAN,GARS_RAT
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000106105
    Target ClassificationN/A

    The target: GARS, gene name: GARS, also named as CMT2D, DSMAV, GlyRS, HMN5, SMAD1. This gene encodes glycyl-tRNA synthetase, one of the aminoacyl-tRNA synthetases that charge tRNAs with their cognate amino acids. The encoded enzyme is an (alpha)2 dimer which belongs to the class II family of tRNA synthetases. It has been shown to be a target of autoantibodies in the human autoimmune diseases, polymyositis or dermatomyositis. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.